Paper17519123
How to treat hypertension in patients with peripheral artery disease.
Clement DL and 1 other. Curr Hypertens Rep, 2007. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. How to treat hypertension in patients with peripheral artery disease. Papers, record 17519123. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17519123
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypertension | Major topic |
| Peripheral Vascular Diseases | Major topic |
| Antihypertensive Agents | |
| Cardiovascular Diseases | |
| Humans | |
| Risk Factors | |
| Risk Reduction Behavior |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2866047 | Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease. | Circulation | 1985 | https://conductscience.org/library/papers/2866047 | PubMed |
| 2 | 3987540 | Effect of felodipine and metoprolol on muscle and skin arteries in hypertensive patients. | Drugs | 1985 | https://conductscience.org/library/papers/3987540 | PubMed |
| 3 | 17161053 | Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials. | Am Heart J | 2006 | https://conductscience.org/library/papers/17161053 | PubMed |
| 4 | 16549646 | ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. | Circulation | 2006 | https://conductscience.org/library/papers/16549646 | PubMed |
| 5 | 16545650 | Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. | J Am Coll Cardiol | 2006 | https://conductscience.org/library/papers/16545650 | PubMed |
| 6 | 16076834 | Temporal trends in the incidence of intermittent claudication from 1950 to 1999. | Am J Epidemiol | 2005 | https://conductscience.org/library/papers/16076834 | PubMed |
| 7 | 10905794 | A clinical approach to the management of the patient with coronary (Co) and/or carotid (Ca) artery disease who presents with leg ischaemia (Lis). | Int Angiol | 2000 | https://conductscience.org/library/papers/10905794 | PubMed |
| 8 | 11130523 | Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. | Lancet | 2000 | https://conductscience.org/library/papers/11130523 | PubMed |
| 9 | 16154016 | Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. | Lancet | 2005 | https://conductscience.org/library/papers/16154016 | PubMed |
| 10 | 12114036 | MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. | Lancet | 2002 | https://conductscience.org/library/papers/12114036 | PubMed |
| 11 | 11786451 | Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. | BMJ | 2002 | https://conductscience.org/library/papers/11786451 | PubMed |
| 12 | 1729621 | Mortality over a period of 10 years in patients with peripheral arterial disease. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1729621 | PubMed |
| 13 | 9400557 | Mortality over four years in SHEP participants with a low ankle-arm index. | J Am Geriatr Soc | 1997 | https://conductscience.org/library/papers/9400557 | PubMed |
| 14 | 15579058 | Hypertension in peripheral arterial disease. | Curr Pharm Des | 2004 | https://conductscience.org/library/papers/15579058 | PubMed |
| 15 | 12409970 | Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk. | J Hypertens | 2002 | https://conductscience.org/library/papers/12409970 | PubMed |
| 16 | 16531616 | Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. | N Engl J Med | 2006 | https://conductscience.org/library/papers/16531616 | PubMed |
| 17 | 9297994 | Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. | Lancet | 1997 | https://conductscience.org/library/papers/9297994 | PubMed |
| 18 | 15153815 | A clinical approach to the management of a patient with suspected renovascular disease who presents with leg ischemia. | Int Angiol | 2003 | https://conductscience.org/library/papers/15153815 | PubMed |
| 19 | 10666287 | Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). | J Vasc Surg | 2000 | https://conductscience.org/library/papers/10666287 | PubMed |
| 20 | 1524519 | Vascular event rates in patients with atherosclerotic cerebrovascular disease. | Arch Neurol | 1992 | https://conductscience.org/library/papers/1524519 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28575088 | Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials. | PLoS One | 2017 | https://conductscience.org/library/papers/28575088 | PubMed |
| 24307487 | Treatment of hypertension in peripheral arterial disease. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/24307487 | PubMed |
| 19602328 | Treatment of hypertension in patients with peripheral arterial disease: an update. | Curr Hypertens Rep | 2009 | https://conductscience.org/library/papers/19602328 | PubMed |
| 19276131 | Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data. | BMJ | 2009 | https://conductscience.org/library/papers/19276131 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17519123
GET https://conductscience.org/api/papers/v1/17519123/references?page=2